Browse result page of THPdb

The total number entries retrieved from this search are 10

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
1025	Th1004	Denileukin diftitox	MGADDVVDSSKSFVMENFSS Full view	255	IIb	Cancer	Ontak	Seragen Inc	Sterile, white, preservative-free, lyophilized powder.	Intravenous(IV) administration	Antineoplastic Agents	Interleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
1406	Th1066	Ibritumomab	Heavy Chain: QAYLQQS Full view	652	IIb	Cancer	Zevalin	Spectrum Pharmaceuticals	Clear, colorless, sterile, pyrogen-free, preservative-free solution that may contain translucent particles.	Intravenous infusion	N.A.	Digoxin
1412	Th1068	Tositumomab	Heavy Chain 1: QAYLQ Full view	1351	IIb	Cancer	Bexxar	Galaxo Smith Kline	Sterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solutionÂÂÂ	Intravenous(IV) administration	N.A.	Bacterial outer membrane,Lipoteichoic acid synthesis
1470	Th1092	Arcitumomab	Heavy chain 1EVKLVES Full view	1310	IIb	Cancer	CEA-Scan	N.A.	N.A.	N.A.	Diagnostic Agents	Vascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
1583	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Clear to slightly opalescent, colorless to light yellow solution	Subcutaneous injection	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1584	Th1125	Golimumab	N.A. Full view	0	IIb	Immunological	Simponi Injection	N.A.	Sterile concentrated solution of the golimumab antibody	Intravenous infusion	Antipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	Tumor necrosis factor
1604	Th1130	Brentuximab Vedotin	Heavy chain:QIQLQQSG Full view	664	IIb	Cancer	Adcetris	Seattle Genetics	Sterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Intravenous infusion	N.A.	Tumor necrosis factor receptor superfamily member 8
1628	Th1139	Certolizumab Pegol	Light chain: DIQMTQS Full view	443	IIb	Immunologcal	Cimzia	UCB	Sterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Subcutaneous injection	TNF inhibitor	Tumor necrosis factor
1636	Th1142	Obinutuzumab	N.A. Full view	0	IIb	Cancer	Gazyva	Genentech	Sterile, clear, colorless to slightly brown, preservative free liquid concentrate	Intravenous infusion	Antineoplastic Agents	B-lymphocyte antigen CD20
1671	Th1159	Gemtuzumab ozogamicin	Light Chain 1: QIVLT Full view	459	IIb	Cancer	Mylotarg	Wyeth pharmaceuticals inc	Sterile, white, preservative-free lyophilized powder	Intravenous infusion	Antineoplastic agents and Immunotoxins	Myeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c